Parenteral Drugs (India)'s quarterly market cap
increased
from Sep. 2021 (₹82.59 Mil) to Dec. 2021 (₹161.31 Mil) but then
declined
from Dec. 2021 (₹161.31 Mil) to Mar. 2022 (₹148.49 Mil).
Parenteral Drugs (India)'s annual market cap
increased
from Mar. 2020 (₹74.54 Mil) to Mar. 2021 (₹94.52 Mil) and
increased
from Mar. 2021 (₹94.52 Mil) to Mar. 2022 (₹148.49 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Parenteral Drugs (India)'s Enterprise Value for Today is ₹1,173.07 Mil.
Parenteral Drugs (India) Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Parenteral Drugs (India)'s Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Parenteral Drugs (India)'s Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Market Cap distribution charts can be found below:
* The bar in red indicates where Parenteral Drugs (India)'s Market Cap falls into.
Parenteral Drugs (India) Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Parenteral Drugs (India)'s Market Cap for the fiscal year that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Parenteral Drugs (India) (BOM:524689) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Parenteral Drugs (India) Market Cap Related Terms
Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Parenteral Drugs (India) (BOM:524689) Business Description
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524689 has been successfully added to your 